CiRC Biosciences
Chicago, IL
CiRC Biosciences operates in the biotechnology industry, focusing on the development of potential cell therapy treatments. The company is currently in the pre-clinical development stage for a treatment for retinitis pigmentosa (RP) and dry age-related macular degeneration. These conditions are related to vision loss, and CiRC Biosciences is working on innovative solutions to address them. The company is a portfolio company of Paragon Biosciences.
circbiosciences.comCompany Details
Founded
- 2019
Employees
- Between 5 - 20 employees
Raised
- $23,835,000
Headquarters Location
- Chicago, IL
Public
- No
Acquired
- No
Founders
- Sai Chavala
Company Collections
These are collections CiRC Biosciences is a part of. Click on the collection name to view similar companies.
CiRC Biosciences' Industries
CiRC Biosciences Headquarters Location
Total Amount Raised: $23,835,000
CiRC Biosciences Funding Rounds
Debt Financing
$7,000,000
Series Unknown
$16,835,000
CiRC Biosciences Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on CiRC Biosciences.